secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001493152-22-031139
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma adopts amended bylaws with proxy access and exclusive forum provisions
--------------------------------------------------------------------------------

- Amended bylaws effective Nov 3, 2022 include proxy access for eligible long-term shareholders.
- Updated advance notice requirements for director nominations and shareholder proposals.
- Added exclusive forum provision for certain legal actions.
- Clarified authority to adjourn shareholder meetings when quorum not present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315222031139/0001493152-22-031139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315222031139/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-031139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer